SELF-TEST FOR ANTIBODIES TO HUMAN IMMUNODEFICIENCY VIRUS (HIV) - ANVISA Registration 80142170054

Access comprehensive regulatory information for SELF-TEST FOR ANTIBODIES TO HUMAN IMMUNODEFICIENCY VIRUS (HIV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80142170054 and manufactured by FUNDAÇÃO OSWALDO CRUZ. The registration is held by FUNDACAO OSWALDO CRUZ with validity until Mar 21, 2032.

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT RAPID DIAGNOSTICS JENA GMBH, CHEMBIO DIAGNOSTICS BRAZIL LTDA., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.